Metanovas

Biotech/Healthcare

Metanovas develops anti-aging and metabolic disease therapeutics. The company combines artificial intelligence with life sciences, using deep learning, knowledge graphs, and multi-omics analysis to understand complex biological networks and decode disease mechanisms.

Latest round: Series A Extension (2026)